Biotech Beach Bum

It’s a hot week for Hepatitis C (HCV) treatment news. This morning local biotech Anadys was cleared by the FDA for more extensive trials of their non-nuc HCV treatment – which in early trials was shown to be extremely effective in reducing virus levels quickly.

 http://www.xconomy.com/san-diego/2009/07/30/anadys-cleared-to-start-hepc-trial/